PressExposure.com

HOME :: Medical / Cardiology

 

  1. Leading New York City Cardiologist, Dr Steven Reisman, Is To Begin Seeing Patients On Wall Street by NewYorkCardiac Center

  2. The New York Cardiac Diagnostic Center accepts most insurance plans. By providing a cardiac consultation with a leading NYC cardiologist in the 10004 zip code, the Center can provide convenient heart disease prevention for those in the Wall Street area.

  3. Sahajanand Medical Technologies, India Receives CE mark on Two Sirolimus Eluting Coronary Stents by Sahajanand Medical Technologies

  4. June 26, 2011. Surat, India. Sahajanand Medical Technologies (SMT) announced today that it has received European CE marking for two Sirolimus eluting coronary stent systems; Supralimus® (Sirolimus eluting stents on stainless steel platform) & Supralimus-Core® (Sirolimus eluting stent on chromium cobalt platform).

  5. Are You a Heart Attack Waiting to Happen? by Better Health Publishing

  6. Dr. Isaac Eliaz is unveiling surprising new ways to prevent the onset of cardiovascular disease.

  7. New York Cardiac Diagnostic Center Helps Patient Determine Heart Disease Risks by New York Cardiac

  8. The New York Cardiac Diagnostic Centers, now located through out the Manhattan area, has helped patients understand and determine if they are at risk for heart disease since 1987.

  9. Portsmouth Regional Hospital Awarded Cycle III Chest Pain Center with PCI (Percutaneous Coronary Intervention) Designation by Portsmouth Regional Hospital

  10. Chest Pain Accreditation: Fast, Coordinated, Expert Care

  11. Valuable Information to Prevent Heart Attack and Heart Disease Now Available through a Website Called Prevent Heart Disease Now by Jamie Freels

  12. Website filled with information, on preventing heart attacks as well as preventing heart disease and even reversing it, now set in motion.

  13. United States Patent and Trademark Office Rejects Patent Infringement Claims by LifeWatch vs Medicomp by Medicomp Inc

  14. Medicomp, Inc. confirmed that it has received an initial ruling by the United States Patent and Trademark Office (USPTO) to reject all claims in regards to LifeWatch patent 7,542,878 (the ‘878 patent).

  15. Medicomp, Inc Announces New Mobile Cardiac Telemetry System for Cardiac Patients by Medicomp Inc

  16. Medicomp introduces the new SAVI Wireless Mobile Cardiac Telemetry system. SAVI Wireless leverages Medicomp’s proprietary Diogenes algorithm and the cellular network to provide real-time analysis and identification of cardiac arrhythmias.

  17. Natural And Effective Remedies for Chronic Bronchitis Treatment by ChronicBronhitisTreatment.net

  18. Learn about the natural remedies for chronic bronchitis treatment.

  19. Catheterization and Cardiovascular Interventions (CCI) Journal Publishes Sahajanand Medical Technologies PAINT Trial 1 Year Results by Sahajanand Medical Technologies Pvt, Ltd.

  20. “The 74th issue of prestigious international journal Catheterization and Cardiovascular Interventions published an article of Sahajanand Medical Technologies PAINT (PercutAneous INTervention) Trial - A randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (Paclitaxel or Sirolimus) compared against Bare stents: 1-year result.”

  21. Six Month Clinical Outcomes of SMT's Supralimus-Sirolimus Eluting Stent is Presented at EuroPCR 09 by Sahajanand Medical Technologies Pvt, Ltd.

  22. Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent with a Biodegradable Polymer (part of the prospective Multicenter E-Series Registry) is presented at EuroPCR 2009.

  23. Pulmonary Hypertension Successfully Treated With Stem Cells by Regenocyte Therapeutic

  24. International medical team announces one year patient results in adult stem cell clinical study for pulmonary hypertension.

  25. Sahajanand Medical Technologies’ Sirolimus Eluting Stent Shows Excellent Outcomes by Sahajananand Medical Technologies

  26. "Sirolimus Eluting Stent for leading drug eluting Stents developer & manufacturer Sahajanand Medical Technologies Pvt. Ltd. (SMT) displayed positive results in MAXIMUS trial that included 100 patients from the Max Heart institute in India"

[ Previous 30 | Display By Oldest | Display By Newest | Next 30 ]

BlackBar
BottomBar
Submit Editorial Guidelines About Contact